A novel compound heterozygous mutation of MYSM1 gene in a patient with bone marrow failure syndrome 4

References

• Biswajit H, Pratim PP, Kumar ST, et al. Aplastic anemia: a common hematological abnormality among peripheral pancytopenia. N Am J Med Sci. 2012;4:384–388.
   PubMedGoogle Scholar
• Young NS. Current concepts in the pathophysiology and treatment of aplastic anemia. Hematology Am Soc Hematol Educ Program. 2013;2013:76–81.
   PubMedGoogle Scholar
• Bahrami E, Witzel M, Racek T, et al. Myb-like, SWIRM, and MPN domains 1 (MYSM1) deficiency: genotoxic stress-associated bone marrow failure and developmental aberrations. J Allergy Clin Immunol. 2017;140:1112–1119.
   PubMed Web of Science ®Google Scholar
• Dietz AC, Savage SA, Vlachos A, et al. Late effects screening guidelines after hematopoietic cell transplantation for inherited bone marrow failure syndromes: consensus statement from the second pediatric blood and marrow transplant consortium international conference on late effects after pediatric HCT. Biol Blood Marrow Transplant. 2017;23:1422–1428.
   PubMed Web of Science ®Google Scholar
• Nijnik A, Clare S, Hale C, et al. The critical role of histone H2A-deubiquitinase Mysm1 in hematopoiesis and lymphocyte differentiation. Blood. 2012;119:1370–1379.
   PubMed Web of Science ®Google Scholar
• Belle JI, Langlais D, Petrov JC, et al. p53 mediates loss of hematopoietic stem cell function and lymphopenia in Mysm1 deficiency. Blood. 2015;125:2344–2348.
   PubMed Web of Science ®Google Scholar
• Zhu P, Zhou W, Wang J, et al. A histone H2A deubiquitinase complex coordinating histone acetylation and H1 dissociation in transcriptional regulation. Mol Cell. 2007;27:609–621.
   PubMed Web of Science ®Google Scholar
• Sun J, Hu X, Gao Y, et al. MYSM1-AR complex-mediated repression of Akt/c-Raf/GSK-3β signaling impedes castration-resistant prostate cancer growth. Aging. 2019;11:10644–10663.
   PubMedGoogle Scholar
• Belle JI, Petrov JC, Langlais D, et al. Repression of p53-target gene Bbc3/PUMA by MYSM1 is essential for the survival of hematopoietic multipotent progenitors and contributes to stem cell maintenance. Cell Death Differ. 2016;23:759–775.
   PubMed Web of Science ®Google Scholar
• Petrov JC, Nijnik A. Mysm1 expression in the bone marrow niche is not essential for hematopoietic maintenance. Exp Hematol. 2017;47:76–82.
   PubMed Web of Science ®Google Scholar
• Förster M, Belle JI, Petrov JC, et al. Deubiquitinase MYSM1 is essential for normal fetal liver hematopoiesis and for the maintenance of hematopoietic stem cells in adult bone marrow. Stem Cells. 2015;24:1865–1877.
   Web of Science ®Google Scholar
• Le Guen T, Touzot F, André-Schmutz I, et al. An in vivo genetic reversion highlights the crucial role of Myb-Like, SWIRM, and MPN domains 1 (MYSM1) in human hematopoiesis and lymphocyte differentiation. J Allergy Clin Immunol. 2015;136:1619–1626.
   PubMed Web of Science ®Google Scholar
• Alsultan A, Shamseldin HE, Osman ME, et al. MYSM1 is mutated in a family with transient transfusion-dependent anemia, mild thrombocytopenia, and low NK- and B-cell counts. Blood. 2013;122:3844–3845.
   PubMed Web of Science ®Google Scholar
• Bluteau O, Sebert M, Leblanc T, et al. A landscape of germ line mutations in a cohort of inherited bone marrow failure patients. Blood. 2018;131:717–732.
   PubMed Web of Science ®Google Scholar
• Ulirsch JC, Verboon JM, Kazerounian S, et al. The genetic landscape of diamond-blackfan anemia. Am J Hum Genet. 2019;104:356.
   PubMed Web of Science ®Google Scholar
• Al-Herz W, Chou J, Delmonte OM, et al. Comprehensive genetic results for primary immunodeficiency disorders in a highly consanguineous population. Front Immunol. 2018;9:3146.
   PubMed Web of Science ®Google Scholar
• Li N, Xu Y, Yu T, et al. Further delineation of bone marrow failure syndrome caused by novel compound heterozygous variants of MYSM1. Gene. 2020;757:144938.
   PubMed Web of Science ®Google Scholar
• Aasland R, Stewart AF, Gibson T. The SANT domain: a putative DNA-binding domain in the SWI-SNF and ADA complexes, the transcriptional co-repressor N-CoR and TFIIIB. Trends Biochem Sci. 1996;21:87–88.
   PubMed Web of Science ®Google Scholar
• Grüne T, Brzeski J, Eberharter A, et al. Crystal structure and functional analysis of a nucleosome recognition module of the remodeling factor ISWI. Mol Cell. 2003;12:449–460.
   PubMed Web of Science ®Google Scholar
• Boyer LA, Latek RR, Peterson CL. The SANT domain: a unique histone-tail-binding module? Nat Rev Mol Cell Biol. 2004;5:158–163.
   PubMed Web of Science ®Google Scholar
• Da G, Lenkart J, Zhao K, et al. Marmorstein R: structure and function of the SWIRM domain, a conserved protein module found in chromatin regulatory complexes. Proc Natl Acad Sci U S A. 2006;103:2057–2062.
   PubMed Web of Science ®Google Scholar
• Hofmann K, Bucher P. The PCI domain: a common theme in three multiprotein complexes. Trends Biochem Sci. 1998;23:204–205.
   PubMed Web of Science ®Google Scholar
• Ponting CP, Aravind L, Schultz J, et al. Eukaryotic signalling domain homologues in archaea and bacteria. Ancient ancestry and horizontal gene transfer. J Mol Biol. 1999;289:729–745.
   PubMed Web of Science ®Google Scholar
• Kouranti I, McLean JR, Feoktistova A, et al. A global census of fission yeast deubiquitinating enzyme localization and interaction networks reveals distinct compartmentalization profiles and overlapping functions in endocytosis and polarity. PLoS Biol. 2010;8:e1000471.
   PubMed Web of Science ®Google Scholar
• Verma R, Aravind L, Oania R, et al. Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome. Science. 2002;298:611–615.
   PubMed Web of Science ®Google Scholar
• Jiang XX, Nguyen Q, Chou Y, et al. Control of B cell development by the histone H2A deubiquitinase MYSM1. Immunity. 2011;35:883–896.
   PubMed Web of Science ®Google Scholar
• Förster M, Farrington K, Petrov JC, et al. MYSM1-dependent checkpoints in B cell lineage differentiation and B cell-mediated immune response. J Leukoc Biol. 2017;101:643–654.
   PubMed Web of Science ®Google Scholar
• Förster M, Boora RK, Petrov JC, et al. A role for the histone H2A deubiquitinase MYSM1 in maintenance of CD8(+) T cells. Immunology. 2017;151:110–121.
   PubMed Web of Science ®Google Scholar
• Wang T, Nandakumar V, Jiang XX, et al. The control of hematopoietic stem cell maintenance, self-renewal, and differentiation by Mysm1-mediated epigenetic regulation. Blood. 2013;122:2812–2822.
   PubMed Web of Science ®Google Scholar
• Huo Y, Li BY, Lin ZF, et al. MYSM1 is essential for maintaining hematopoietic stem cell (HSC) quiescence and survival. Med Sci Monit. 2018;24:2541–2549.
   PubMed Web of Science ®Google Scholar